FJN: [1-[2-(1,2,3,4,4~{a},9~{a}-hexahydroacridin-9-ylamino)ethyl]-1,2,3-triazol-4-yl]methyl-[[2-[[(10~{b}~{S})-6-oxidanylidene-2,3,4,10~{b}-tetrahydro-1~{H}-pyrido[2,1-a]isoindol-10-yl]carbamoylamino]pyridin-4-yl]methyl]-methyl-azanium
FJN is a Ligand Of Interest in 6H13 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6H13_FJN_A_604 | 12% | 3% | 0.279 | 0.81 | 3.17 | 3.15 | 19 | 29 | 1 | 2 | 100% | 1 |
| 6H13_FJN_B_605 | 11% | 3% | 0.29 | 0.804 | 3.16 | 3.18 | 17 | 31 | 0 | 2 | 100% | 0.88 |
